LOGIN
ID
PW
MemberShip
2025-09-06 00:41
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Risk-Sharing Agreements in the EU: A Systematic Review
Risk-Sharing Agreements in the EU: A Systematic Review
of Major Trends
Input Time : 2019-11-15
[Download file]
go back
OPINION
[Reporter¡¯s View] Be aware, be prepared
Reporter's view |
Eo, Yun-Ho
[Reporter's View] New opportunities have emerged for K-Bio
Reporter's view |
Son, Hyung Min
[Reporter's View] Innovativeness and trust in healthcare AI
Reporter's view |
Whang, byung-woo
INTERVIEW
Dong-A ST launches Sterlara biosimilar Imuldosa in the US
V-olet challenges to become a blockbuster fat-destroying inj
Kim Seul-ki, PM of Daewoong Pharmaceutical's Nabota Business Team
'Viatris will lead market with innovation and leadership'
Bill Schuster, Representative Director & Country Manager of Viatris Korea
"Livtencity offers new CMV trt for transplant patients"
Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
¡®SGLT2i+TZD promising for diabetics with fatty liver risk¡¯
Cheol-Young Park, Professor of Endocrinology at Kangbuk Samsung Hospital
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
"MFDS' data-based drug shortage response"
2
Fruzaqla may be prescribed at general hospitals in KOR
3
COVID-19 response more important for high-risk groups
4
HIRA "Reimb application of Wegovy has not been filed"
5
Patent suits active to release Rinvoq generics
6
Novo Nordisk, Kakao Health sign digital healthcare MOU
7
CKD says, "New ADC drug enters first clinical trials"
8
Moderna¡¯s latest variant-targeted COVID-19 vaccine approved
9
MFDS allocates KRW 812.2 billion for next year's budget plan
10
[Reporter's View] New opportunities have emerged for K-Bio